Acs Medicinal Chemistry Letters

• 

  Publication Venue For

  • Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV Activity..  11:2290-2293. 2020
  • Synthesis and Evaluation of a 18F-Labeled Triazinediamine Analogue for Imaging Mutant IDH1 Expression in Gliomas by PET..  9:606-611. 2018
  • Elimination of HIV-1 Latently Infected Cells by Gnidimacrin and a Selective HDAC Inhibitor..  9:268-273. 2018
  • Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors..  8:1199-1203. 2017
  • Aloperine and Its Derivatives as a New Class of HIV-1 Entry Inhibitors..  7:240-244. 2016
  • Phenolic diterpenoid derivatives as anti-influenza a virus agents..  6:355-358. 2015
  • Identification and synthesis of quinolizidines with anti-influenza a virus activity..  5:942-946. 2014
  • Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties..  5:905-910. 2014
  • Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention..  5:485-490. 2014
  • Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor..  4:1005-1010. 2013
  • Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor..  4:846-851. 2013
  • Discovery of dabrafenib: A selective inhibitor of Raf Kinases with antitumor activity against B-Raf-driven tumors.  4:358-362. 2013
  • From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules..  3:721-725. 2012
  • Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators..  3:925-930. 2012